Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCKDK | O14874 | 1/20 | 0.49 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.49 |
| ▸ | MIF | P14174 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 7/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.41 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | GFER | P55789 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24343672 | 0.90 | BCKDK (0.45) | BCKDKMCL1RXFP1MIFESR1 | |
| SCHEMBL24343656 | 0.90 | KDM4E (0.46) | BCKDKMCL1RXFP1MIFESR1 | |
| SCHEMBL4922527 | 0.87 | BCKDK (0.53) | BCKDKMCL1RXFP1NPC1RAB9A | |
| SCHEMBL29980342 | 0.87 | HTT (0.44) | ESR1ESR2RAB9AHSD17B10KDM4E | |
| SCHEMBL31228783 | 0.87 | BCKDK (0.53) | BCKDKMCL1RXFP1NPC1RAB9A | |
| SCHEMBL3874783 | 0.87 | HTT (0.44) | ESR1ESR2RAB9AHSD17B10KDM4E | |
| SCHEMBL22375225 | 0.82 | BCKDK (0.50) | BCKDKMCL1RXFP1TSHRNPC1 | |
| SCHEMBL16527316 | 0.81 | KDM4E (0.61) | BCKDKMCL1RXFP1MIFESR1 | |
| SCHEMBL24343663 | 0.79 | KDM4E (0.50) | MIFESR1TSHRESR2HSD17B10 | |
| SCHEMBL31012019 | 0.77 | KDM4E (0.61) | BCKDKMCL1RXFP1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357209-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | LT MATERIALS CO., LTD. (KR) | 2023-11-09 | — | — | US | disclosed |
| US-20230286882-A1 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND AND DEUTERATED REACTION COMPOSITION | LG CHEM, LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-20230286882-A1 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND AND DEUTERATED REACTION COMPOSITION | LG CHEM, LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| EP-4177238-A1 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND AND DEUTERATED COMPOSITION | Lg Chem, Ltd. (KR) | 2023-05-10 | — | — | EP | disclosed |
| US-20230018666-A1 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND, AND DEUTERATED REACTIVE COMPOSITION | LG CHEM, LTD. (KR) | 2023-01-19 | — | — | US | disclosed |
| WO-2022045825-A1 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND AND DEUTERATED COMPOSITION | 주식회사 엘지화학 | 2022-03-03 | — | — | WO | disclosed |
| US-20080139824-A1 | DIBENZOTHIOPHENE OXIDE COMPOUND, AND PROCESS FOR PRODUCING THE SAME | SEKINE CHIZU | 2008-06-12 | — | — | US | disclosed |
| US-20070057229-A1 | COMPOUND HAVING PHENYLACETYLENE STRUCTURE, LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC PRODUCT, OPTICAL OR LIQUID CRYSTAL ELEMENT, DIBENZOTHIOPHENE COMPOUND, INTERMEDIATE, AND PROCESS FOR PRODUCING THE SAME | SEKINE CHIZU | 2007-03-15 | — | — | US | disclosed |
| US-7135579-B2 | Dibenzothiophene oxide compound, and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2006-11-14 | — | — | US | disclosed |
| US-6849202-B2 | COMPOUND HAVING PHENYLACETYLENE STRUCTURE, LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC PRODUCT, OPTICAL OR LIQUID CRYSTAL ELEMENT, DIBENZOTHIOPHENE COMPOUND, INTERMEDIATE, AND PROCESS FOR PRODUCING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-02-01 | — | — | US | disclosed |
| US-20040232384-A1 | Compound having phenylacetylene structure, liquid crystal composition, polymer, optically anisotropic product, optical or liquid crystal element, dibenzothiophene compound, intermediate, and process for producing the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-11-25 | — | — | US | disclosed |
| US-20020110650-A1 | Compound having phenylacetylene structure, liquid crystal composition, polymer, optically anisotropic product, optical or liquid crystal element, dibenzothiophene compound, intermediate, and process for producing the same | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2002-08-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230018666-A1 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND, AND DEUTERATED REACTIVE COMPOSITION | AHR, TYR, ARNT | BCKDK 3009/4885MCL1 2478/4885RXFP1 3498/4885 |
| US-20230286882-A1 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND AND DEUTERATED REACTION COMPOSITION | AHR, PAH, HDHD5 | BCKDK 855/4885MCL1 3547/4885RXFP1 3710/4885 |
| US-20230357209-A1 | HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE | CYP1A1, CYP1B1, ODC1 | BCKDK 986/4885MCL1 1358/4885RXFP1 4578/4885 |
| US-20070057229-A1 | COMPOUND HAVING PHENYLACETYLENE STRUCTURE, LIQUID CRYSTAL COMPOSITION, POLYMER, OPTICALLY ANISOTROPIC PRODUCT, OPTICAL OR LIQUID CRYSTAL ELEMENT, DIBENZOTHIOPHENE COMPOUND, INTERMEDIATE, AND PROCESS FOR PRODUCING THE SAME | CCNT1, CCNA1, CCNT2 | BCKDK 2770/4885MCL1 3161/4885RXFP1 2831/4885 |
| US-20040232384-A1 | Compound having phenylacetylene structure, liquid crystal composition, polymer, optically anisotropic product, optical or liquid crystal element, dibenzothiophene compound, intermediate, and process for producing the same | CCNT1, BPNT1, PEAK1 | BCKDK 2841/4885MCL1 3538/4885RXFP1 3460/4885 |
| US-20080139824-A1 | DIBENZOTHIOPHENE OXIDE COMPOUND, AND PROCESS FOR PRODUCING THE SAME | CCNT1, CCNA1, BPNT1 | BCKDK 3145/4885MCL1 2960/4885RXFP1 3970/4885 |
| US-20020110650-A1 | Compound having phenylacetylene structure, liquid crystal composition, polymer, optically anisotropic product, optical or liquid crystal element, dibenzothiophene compound, intermediate, and process for producing the same | CCNT1, NAT1, PEAK1 | BCKDK 3127/4885MCL1 3619/4885RXFP1 3236/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.